We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
-16.7%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$17B
AUM Growth
-$5.13B
Cap. Flow
-$794M
Cap. Flow %
-4.67%
Top 10 Hldgs %
43.02%
Holding
494
New
36
Increased
156
Reduced
156
Closed
61

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$108M
2
V icon
Visa
V
+$102M
3
MELI icon
Mercado Libre
MELI
+$73M
4
ENPH icon
Enphase Energy
ENPH
+$58.6M
5
SNOW icon
Snowflake
SNOW
+$57.5M

Sector Composition

Rank Sector Weight
1 Technology 30.66%
2 Industrials 25.1%
3 Healthcare 17.44%
4 Financials 14.96%
5 Communication Services 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMW
301
DELISTED
VMware, Inc
VMW
$665K ﹤0.01%
5,831
-925
-14% -$105K
CTXS
302
DELISTED
Citrix Systems Inc
CTXS
$665K ﹤0.01%
6,840
-1,437
-17% -$143K
ADSK icon
303
Autodesk
ADSK
$47.5B
$664K ﹤0.01%
3,864
+1,079
+39% +$207K
QRVO icon
304
Qorvo
QRVO
$10.1B
$650K ﹤0.01%
6,893
+1,887
+38% +$204K
AZTA icon
305
Azenta
AZTA
$1.42B
$647K ﹤0.01%
+8,975
New +$671K
HUBB icon
306
Hubbell
HUBB
$23.3B
$637K ﹤0.01%
3,567
-215
-6% -$40.5K
QS icon
307
QuantumScape Corp
QS
$3.14B
$629K ﹤0.01%
73,236
-4,480
-6% -$59.8K
IRTC icon
308
iRhythm Holdings
IRTC
$3.68B
$621K ﹤0.01%
5,750
-3,941
-41% -$522K
ARWR icon
309
Arrowhead Research
ARWR
$10.6B
$605K ﹤0.01%
17,182
AOS icon
310
A.O. Smith
AOS
$7.71B
$567K ﹤0.01%
10,368
+1,214
+13% +$72.8K
BLK icon
311
Blackrock
BLK
$163B
$548K ﹤0.01%
+900
New +$586K
BEKE icon
312
KE Holdings
BEKE
$17.8B
$507K ﹤0.01%
28,221
+4,134
+17% +$58.2K
RRX icon
313
Regal Rexnord
RRX
$10.2B
$506K ﹤0.01%
4,454
-5,375
-55% -$684K
PCRX icon
314
Pacira BioSciences
PCRX
$970M
$501K ﹤0.01%
8,595
+5,250
+157% +$344K
LAC
315
DELISTED
Lithium Americas Corp. Common Shares
LAC
$501K ﹤0.01%
21,641
-467
-2% -$11.9K
FSLR icon
316
First Solar
FSLR
$22B
$483K ﹤0.01%
7,084
-1,242
-15% -$88.4K
ACH
317
Accendra Health
ACH
$82.3M
$468K ﹤0.01%
14,888
VIVO
318
DELISTED
Meridian Bioscience Inc
VIVO
$448K ﹤0.01%
14,718
-6,917
-32% -$187K
SLRC icon
319
SLR Investment Corp
SLRC
$658M
$439K ﹤0.01%
30,000
-253,615
-89% -$4.08M
FSR
320
DELISTED
Fisker Inc.
FSR
$438K ﹤0.01%
51,089
-3,480
-6% -$36.1K
ALTR
321
DELISTED
Altair Engineering Inc
ALTR
$437K ﹤0.01%
8,326
QDEL icon
322
QuidelOrtho
QDEL
$747M
$435K ﹤0.01%
+4,475
New +$456K
NTES icon
323
NetEase
NTES
$76.3B
$427K ﹤0.01%
4,570
-1,364
-23% -$130K
PGNY icon
324
Progyny
PGNY
$2.12B
$423K ﹤0.01%
14,558
+5,685
+64% +$204K
PRVA icon
325
Privia Health
PRVA
$2.64B
$423K ﹤0.01%
+14,530
New +$369K

Similar funds

Polar Capital Holdings's Q2 2022 Portfolio in Review

As of Q2 2022, Polar Capital Holdings held 494 positions worth $17B, down 23% from $22.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Polar Capital Holdings withdrew a net $794M in Q2 2022, closing 61 positions and reducing 156 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $147M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Polar Capital Holdings opened a new position in Sanofi worth $36.3M.

  • Polar Capital Holdings's largest Q2 2022 buy was Sanofi: 725,000 shares worth $36.3M.
  • Polar Capital Holdings added most to Salesforce in Q2 2022, an estimated $108M increase.
  • Polar Capital Holdings's biggest Q2 2022 reduction was Applied Materials, cutting an estimated $116M.
  • Polar Capital Holdings fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, selling an estimated $147M.
  • Polar Capital Holdings's ten largest holdings make up 43% of its $17B portfolio in Q2 2022.
  • Polar Capital Holdings opened 36 new positions and closed 61 in Q2 2022.
  • Polar Capital Holdings's portfolio value fell 23% quarter-over-quarter to $17B.

Based on Polar Capital Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.